Suspension of Bitstamp and Gemini as Constituent Exchanges for CF Artificial Superintelligence Alliance-Dollar, and CF Injective-Dollar indices

Following a review of executed trades, the Administrator determined that neither Bitstamp nor Gemini met the average daily volume criteria for the purpose of launching the proposed US Settlement Prices for these USD pairs.

Suspension of Bitstamp and Gemini as Constituent Exchanges for CF Artificial Superintelligence Alliance-Dollar, and CF Injective-Dollar indices

The Administrator announces the suspension of Bitstamp and Gemini as CF Constituent Exchanges for the following indices within the CF Digital Asset Index Family – Single Asset Series, effective November 3rd, 2025:

  • CF Artificial Superintelligence Alliance-Dollar Spot Rate (FETUSD_RTI) - Bitstamp suspended
  • CF Injective-Dollar Spot Rate (INJUSD_RTI) - Gemini Suspended

Rationale

The Administrator has proposed the launch of the CF Artificial Superintelligence Alliance-Dollar US Settlement Price, and CF Injective-Dollar US Settlement Price. As per the CF Constituent Exchanges Criteria, a trading venue is eligible as a Constituent Exchange in any of the CF Cryptocurrency Index Family indices, if the average daily volume contribution during the observation window for the Relevant Pair is greater than 3% of the other Constituent Exchanges in combination for 45 consecutive days.

Following a review of executed trades, the Administrator determined that neither Bitstamp nor Gemini met the average daily volume criteria for the purpose of launching the proposed US Settlement Prices. As a result, Bitstamp and Gemini will be suspended as CF Constituent Exchanges for the indices listed above. These suspensions are indefinite.

Implementation Date

The suspensions will take effect at approximately 11:00 a.m. London Time, on November 3rd, 2025. The process has been conducted under the supervision of the CF Cryptocurrency Index Family Oversight Function.

Questions and complaints

For questions regarding this suspension, please contact: info@cfbenchmarks.com.

To submit a confidential complaint, please email: complaints@cfbenchmarks.com.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.